Kidney sequelae in 281 Shiga toxin–producing Escherichia coli-hemolytic uremic syndrome patients after a median follow-up of 12 years

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Pediatric nephrology (Berlin, West)

• Publication date

  2023-10-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00467-023-06183-7PMID 37880381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A decrease in the incidence of Shiga toxin‐related hemolytic uremic syndrome as a cause of kidney transplantation at an argentine referral center

  2023cited by this paper
• Long-term kidney outcomes in non-dialyzed children with Shiga-toxin Escherichia coli associated hemolytic uremic syndrome

  2023cited by this paper
• Acute peritoneal dialysis, complications and outcomes in 389 children with STEC-HUS: a multicenter experience

  2021cited by this paper
• Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli infection in Argentina: update of serotypes and genotypes and their relationship with severity of the disease

  2021cited by this paper
• Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)

  2021cited by this paper
• Diagnostic sensitivity of extended renal and hematologic criteria to define hemolytic uremic syndrome.

  2021cited by this paper
• Risk Factors for Short- and Long-Term Outcomes in Children With STEC-HUS/D+ HUS: A Single-Center Experience

  2018influential reference
• Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome

  2018cited by this paper
• Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood

  2018cited by this paper
• A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network

  2018cited by this paper
• Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort

  2018cited by this paper
• Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents

  2017cited by this paper
• Flynn JT, Kaelber DC, Baker-Smith CM, et al; SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3):e20171904

  2017cited by this paper
• [Microalbuminuria in pediatric patients diagnosed with hemolytic uremic syndrome].

  2015cited by this paper
• Long-term follow-up of children with typical hemolytic uremic syndrome.

  2015cited by this paper
• Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death.

  2015cited by this paper
• Time to change the definition of hemolytic uremic syndrome.

  2014cited by this paper
• Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome

  2013cited by this paper
• Long-term outcomes of Shiga toxin hemolytic uremic syndrome

  2013cited by this paper
• Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae.

  2012influential reference
• Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada

  2012cited by this paper
• Puberty is associated with increased deterioration of renal function in patients with CKD: data from the ItalKid Project

  2012cited by this paper
• Notice

  2012cited by this paper
• Acute Renal Replacement Therapy in Children with Diarrhea-Associated Hemolytic Uremic Syndrome: A Single Center 16 Years of Experience

  2011cited by this paper
• Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy

  2011cited by this paper
• Adolescents: Evaluation, Classification, and Stratification Clinical Practice Guidelines for Chronic Kidney Disease in Children and National Kidney Foundation's Kidney Disease Outcomes Quality Initiative

  2010influential reference
• Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome

  2008influential reference
• Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome

  2008cited by this paper
• Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome

  2007cited by this paper
• Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis

  2007cited by this paper
• Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome.

  2005cited by this paper
• National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

  2003cited by this paper
• National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

  2003cited by this paper
• Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features

  1997influential reference
• Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.

  1996cited by this paper
• Long term renal outcome of childhood haemolytic uraemic syndrome.

  1991cited by this paper
• Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome.

  1991influential reference
• A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

  1976cited by this paper

• Role of INM004 Shiga-toxin antibodies in treatment of STEC-HUS

  2025cites this paper
• INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome

  2025cites this paper
• Enfermedad renal crónica en el niño

  2025cites this paper
• Haemolytic uremic syndrome as a cause of chronic kidney disease stage 5 in children is in retreat: results from the Polish Registry of Kidney Replacement Therapy in children (2000–2023)

  2024influential citation
• Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children

  2024cites this paper
• Maladie rénale chronique de l’enfant

  2024cites this paper
• Dynamic evolution of kidney function in patients with STEC-hemolytic uremic syndrome followed for more than 15 years: unexpected changes

  2024influential citation
• Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli–associated hemolytic uremic syndrome

  2024cites this paper